Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In this randomized, double-blind, placebo-controlled trial, 140 patients with uncomplicated falciparum malaria were randomized to rosiglitazone 4 mg BID for four days vs. placebo, in addition to atovaquone/proguanil.

Rosiglitazone for Adjunctive Treatment of Malaria